Select Page

Covid-19 Vaccine:

Booster Dose

Covid-19 Vaccine:

Third Dose FOR IMMUNOCOMPROMISED

You MUST bring your COVID-19 vaccination record card to your vaccination appointment. If you lost your vaccination record, you MUST request a new card prior to arriving for a vaccination appointment.

COVID-19 VACCINE:

BOOSTER DOSES

The Will County Health Department, Illinois Department of Public Health (IDPH), and Centers for Disease Control (CDC) is recommending anyone 12 years and older get a COVID-19 vaccine booster five months after completing their primary two-dose series of Moderna or Pfizer, or two-months after receiving the one-dose Johnson & Johnson vaccine.

Moderna
Booster Dose

WHO IS ELIGIBLE:
Individuals 18 years and older

DOSAGE:
½ dose

WHEN ARE YOU ELIGIBLE:
At least five-months after the initial two-dose series was administered

WANT TO SWITCH BRANDS?
Yes, you can receive a single booster dose of Moderna as long as you completed a one or two-dose series with a different COVID-19 vaccine.

Pfizer
Booster Dose

WHO IS ELIGIBLE:
Individuals 12 years and older

DOSAGE:
Full Dose

WHEN ARE YOU ELIGIBLE:
At least five-months after the initial two-dose series was administered

WANT TO SWITCH BRANDS?
Yes, you can receive a single booster dose of Pfizer as long as you completed a one or two-dose series with a different COVID-19 vaccine.

Johnson & Johnson
Booster Dose

WHO IS ELIGIBLE:
Individuals 18 years and older

DOSAGE:
Full Dose

WHEN ARE YOU ELIGIBLE:
At least two-months after a single dose primary vaccination was administered

WANT TO SWITCH BRANDS?
Yes, you can receive a single booster dose of Johnson & Johnson as long as you completed a two-dose series with a different COVID-19 vaccine.

Moderna Booster Dose

Ages 18+

Available at the Joliet location only

PFIZER BOOSTER DOSE

Ages 12+

Joliet Location Appointments

Bolingbrook Location Appointments

Johnson & Johnson Booster Dose

Ages 18+

Joliet Location Appointments

Bolingbrook Location Appointments

COVID-19 VACCINE:

THIRD DOSE

FOR IMMUNOCOMPROMISED

Third COVID-19 Vaccine Doses for People who are Moderately or Severely Immunocompromised.

A Third dose is NOT a booster dose!

The Food and Drug Administration (FDA) amended the Emergency Use Authorizations (EUAs) for both the Pfizer-BioNTech COVID-19 Vaccine and Moderna COVID-19 Vaccine to allow a third dose to be administered to people who are moderately or severely immunocompromised following a primary mRNA vaccine series.

Subsequently, CDC’s Advisory Committee on Immunization Practices (ACIP) recommended that people with moderately to severely compromised immune systems receive a third dose of mRNA COVID-19 vaccine at least 4 weeks after their second dose, for a total of three doses. CDC Director Dr. Rochelle Walensky endorsed those recommendations. See the full CDC Media Statement here. 

WHO IS ELIGIBLE FOR A THIRD DOSE OF COVID-19 VACCINE?

Currently, CDC is recommending that moderately to severely immunocompromised people ages 5 and up receive an additional dose. This includes people who have:

  • Been receiving active cancer treatment for tumors or cancers of the blood
  • Received an organ transplant and are taking medicine to suppress the immune system
  • Received a stem cell transplant within the last 2 years or are taking medicine to suppress the immune system
  • Moderate or severe primary immunodeficiency (such as DiGeorge syndrome, Wiskott-Aldrich syndrome)
  • Advanced or untreated HIV infection
  • Active treatment with high-dose corticosteroids or other drugs that may suppress your immune response

If your condition or medication isn’t on this list and you think you have a weakened immune system, talk to your healthcare provider about your medical condition and whether getting an additional dose is appropriate.

Individuals can self-attest and receive the third dose wherever vaccines are offered. This will help ensure there are not additional barriers to access for this vulnerable population receiving a needed third dose.

WHEN ARE YOU ELIGIBLE

The third dose of an mRNA COVID-19 vaccine should be the same vaccine as the initial series and administered at least four weeks after completing a primary mRNA COVID-19 vaccine series.

ADDITIONAL CONSIDERATIONS FOR IMMUNOCOMPROMISED INDIVIDUALS

While vaccination is likely to increase protection in this population, even after vaccination, people who are immunocompromised should continue follow current prevention measures (including wearing a mask, staying 6 feet apart from others they do not live with, and avoiding crowds and poorly ventilated indoor spaces) to protect themselves and those around them against COVID-19 until advised otherwise by their healthcare provider.

Moderna Third Dose FOR IMMUNOCOMPROMISED

Joliet Location Appointments

Pfizer Third Dose FOR IMMUNOCOMPROMISED Ages 5-11

Joliet Location Appointments

Pfizer Third Dose FOR IMMUNOCOMPROMISED Ages 12+

Joliet Location Appointments

Bolingbrook Location Appointments